4-Methylmorpholine → (R)-3-{4-[4-(4-chlorobenzoyl)piperidine-1-carbonyl]phenyl}-4-isopropyloxazolidin-2-one
反応式
[CH:1]([C@@H:4]1[CH2:8][O:7][C:6](=[O:9])[N:5]1[C:10]1[CH:18]=[CH:17][C:13]([C:14]([OH:16])=O)=[CH:12][CH:11]=1)([CH3:3])[CH3:2].Cl.[Cl:20][C:21]1[CH:26]=[CH:25][C:24]([C:27]([CH:29]2[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]2)=[O:28])=[CH:23][CH:22]=1.O.[Cl-].COC1N=C(OC)N=C([N+]2(C)CCOCC2)N=1.CN1CCOCC1>CO.C(Cl)(Cl)Cl>[Cl:20][C:21]1[CH:22]=[CH:23][C:24]([C:27]([CH:29]2[CH2:34][CH2:33][N:32]([C:14]([C:13]3[CH:12]=[CH:11][C:10]([N:5]4[C@H:4]([CH:1]([CH3:2])[CH3:3])[CH2:8][O:7][C:6]4=[O:9])=[CH:18][CH:17]=3)=[O:16])[CH2:31][CH2:30]2)=[O:28])=[CH:25][CH:26]=1参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
To a mixture of (R)-4-(4-isopropyl-2-oxooxazolidin-3-yl)benzoic acid (499 mg) described in Preparation Example 18, (4-chlorophenyl)piperidin-4-ylmethanone hydrochloride (520 mg) and 4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMT-MM)(829 mg) were added chloroform (3 mL), methanol (3 mL) and N-methylmorpholine (220 μL) and the mixture was stirred at room temperature overnight. After evaporation of the solvent, the residue was purified by column chromatography (chloroform:methanol) to give the title compound (728 mg).
後処理
- customAfter evaporation of the solvent
- customthe residue was purified by column chromatography (chloroform:methanol)
出典と根拠
- ORDレコード
- ord-92b208132c954507a34657e64a25aeb8
- 出典データセット
- uspto-grants-2013_01
- 特許番号
- US08354401B2
反応ノート
読み込み中…